abstract |
More particularly, the present invention relates to a method for producing a 2,2'-bis-thiazole-based compound and an antitumor agent as a histone deacetylase inhibitor. The present invention relates to a thiazole-based compound, , A therapeutic agent for autoimmune disease, a therapeutic agent for type II diabetes and its complications or a therapeutic agent for neurodegenerative lesions. |